| Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma. | |
| Liu, Bo; Liu, Jingping; Liao, Yuxiang; Jin, Chen; Zhang, Zhiping; Zhao, Jie; Liu, Kun; Huang, Hao; Cao, Hui; Cheng, Quan* | |
| 刊名 | Medical science monitor : international medical journal of experimental and clinical research
 |
| 2019 | |
| 卷号 | 25页码:3624-3635 |
| 关键词 | Drug resistance Glioblastoma Prognosis Radiotherapy |
| ISSN号 | 1643-3750 |
| DOI | 10.12659/MSM.916648 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000468035900002 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/5710352 |
| 专题 | 湖南中医药大学 |
| 作者单位 | 1.[Liu, Bo 2.Liu, Jingping 3.Liao, Yuxiang 4.Jin, Chen 5.Cheng, Quan 6.Zhao, Jie 7.Zhang, Zhiping] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Liu, Bo,Liu, Jingping,Liao, Yuxiang,et al. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.[J]. Medical science monitor : international medical journal of experimental and clinical research,2019,25:3624-3635. |
| APA | Liu, Bo.,Liu, Jingping.,Liao, Yuxiang.,Jin, Chen.,Zhang, Zhiping.,...&Cheng, Quan*.(2019).Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma..Medical science monitor : international medical journal of experimental and clinical research,25,3624-3635. |
| MLA | Liu, Bo,et al."Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.".Medical science monitor : international medical journal of experimental and clinical research 25(2019):3624-3635. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论